Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ahmad Hachem"'
Autor:
Fatme Charafeddine, Ahmad Hachem, Nadine Kibbi, Mohammad Abutaqa, Fadi Bitar, Ziad Bulbul, Issam El-Rassi, Mariam Arabi
Publikováno v:
Journal of the Saudi Heart Association, Vol 31, Iss 3, Pp 125-129 (2019)
Objectives: To describe the first Lebanese fetal echocardiography experience for prenatal diagnosis of congenital heart diseases (CHD), showcase successes, and hurdles. Methods: This was a retrospective study from January 2014 to December 2017. A tot
Externí odkaz:
https://doaj.org/article/c4b980852e7e41eb99e0a817b50a44b2
Autor:
Nibal Chamoun, Hady Ghanem, Ahmad Hachem, Essa Hariri, Christelle Lteif, Hanine Mansour, Hani Dimassi, Richard Zalloum, Georges Ghanem
Publikováno v:
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Thromboprophylaxis dosing strategies using enoxaparin in elderly patients with renal disease are limited, while dose adjustments or monitoring of anti-Xa levels are recommended. We sought to evaluate the efficacy and safety of eno
Externí odkaz:
https://doaj.org/article/8dea39a4a3ef406ebfb3272f3d0c652f
Publikováno v:
Diyala Journal of Medicine, Vol 5, Iss 2 (2019)
Objective: To measure the serum level of IL4, IL10 and IFN-gamma of Atopic patients before and after treatment with tacrolimus ointment or topical steroid by using enzyme linked immunosorbant assay (ELISA) to evaluate the disease activity. Methods
Externí odkaz:
https://doaj.org/article/42448b943f054c7c95d415311ffa3ca6
Publikováno v:
International Journal of Clinical Research. 1:113-123
Background: Antiretroviral drug resistance remains a significant problem in the clinical management of patients infected with the Human Immunodeficiency Virus type-1. Aim: This study investigates and reports data on the molecular characterization of
Autor:
James B Cutrell, Oliver Sabot, Kelly C. Sanders, Roly D. Gosling, Daniel Maxwell, Ally Olotu, Michelle S. Hsiang, Alejandro Llanos-Cuentas, Ahmad Hachem
Low- and middle-income countries (LMICs) face significant challenges in the control of COVID-19, given limited resources, especially for inpatient care. In a parallel effort to that for vaccines, the identification of therapeutics that have near-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74fbab996a41b0052de8706b1f57fc05
https://doi.org/10.1101/2021.03.22.21253621
https://doi.org/10.1101/2021.03.22.21253621
Autor:
Kelly C. Sanders, Ally Olotu, James B Cutrell, Alejandro Llanos-Cuentas, Ahmad Hachem, Daniel Maxwell, Roly Gosling, Oliver Sabot, Michelle S. Hsiang
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Low- and middle-income countries (LMICs) face significant challenges in the control of COVID-19, given limited resources, especially for inpatient care. In a parallel effort to that for vaccines, the identification of therapeutics that have near-term
Publikováno v:
Current Cardiology Reviews
The role of proprotein convertase subtilisin/kexin type 9 (PCSK9) recently emerged as a crucial component in lipid homeostasis after extensive investigational efforts conducted to unveil the complex mechanisms associated with familial hypercholestero
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:126-132
Hydroxyurea, blood transfusions, and hematopoietic stem cell transplantation represent the 3 disease-modifying therapies in children with sickle cell disease (SCD). Blood transfusions play an increasingly important role in both prevention and managem
Autor:
Elie K. Haddad, Christelle Lteif, Ahmad Hachem, Ahmad Naja, Essa Hariri, George A. Sarkis, Nibal Chamoun, Georges Ghanem
Publikováno v:
Lebanese Medical Journal. 65:7-14
Autor:
Georges Ghanem, Hady Ghanem, Hanine Mansour, Christelle Lteif, Ahmad Hachem, Hani Dimassi, Nibal Chamoun, Richard Zalloum, Essa Hariri
Publikováno v:
BMC Pharmacology & Toxicology
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-9 (2019)
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-9 (2019)
Background Thromboprophylaxis dosing strategies using enoxaparin in elderly patients with renal disease are limited, while dose adjustments or monitoring of anti-Xa levels are recommended. We sought to evaluate the efficacy and safety of enoxaparin 2